Does reducing the number of intradetrusor botulinum toxin type A injection sites affect efficacy and safety in patients with spinal cord injury?

Objective To investigate the clinical effect and safety of different numbers of botulinum toxin type A (BTX-A) bladder injections in the treatment of neurogenic detrusor overactivity (NDO).Design A single-blind randomized control trial.Setting A single spinal cord injury (SCI) rehabilitation center in China.Participants A total of 44 patients with spinal cord injury and neurogenic detrusor overactivity who underwent intradetrusor injection of 200 U BTX-A were enrolled. The cohort included 34 men and 10 women.Interventions They were randomly divided into two groups of 30 vs. 20 sites of injection with 200 U BTX-A.Outcome Measures Urodynamic parameters such as maximum detrusor pressure at first DO (PdetmaxDO), volume at the first involuntary detrusor contraction, were measured at baseline and week 12 after injection. Mean urine volume per catheterization(V-CIC), scores of the Incontinence Specific Quality of Life Instrument (I-QoL) were also recorded before and after treatment.Results At the endpoint, both the urodynamic parameters and volume of catheterization improved significantly, without a significant difference between the two groups. Mean decreases in the maximum detrusor pressure were −31.95 and −25.77 cmH2O in the 20- and 30-injection groups. The increases in volume at the first involuntary detrusor contraction from baseline were +130.86 and +122.73 ml, respectively. There was no significant difference in the change in incontinence severity or I-QoL improvement between the two groups. The urinary incontinence episodes per week decreased from 48.41 ± 6.71–17.50 ± 16.17 and from 53.27 ± 11.33–22.91 ± 18.94 in the 20- and 30-injection groups, respectively (all P < 0.001). There were eight and seven patients with complete dryness after treatment.Conclusions When the total dose of 200 U was maintained, reducing the number of injection sites from 30 to 20 had a similar therapeutic effect in NDO without compromising safety. Clinically, this approach may be advantageous in terms of reducing the operating time and improving patient comfort.

Authors

Institutions

Publication Details

Journal
Journal of Spinal Cord Medicine
Published
2026-11-12
DOI
https://doi.org/10.1080/10790268.2026.2681359
Primary Topic
Urinary Bladder and Prostate Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Does reducing the number of intradetrusor botulinum toxin type A injection sites affect efficacy and safety in patients with spinal cord injury?

Huang Maping, 刘秋玲, 谢克基, Heyi Zheng et al.
Journal of Spinal Cord Medicine
Urinary Bladder and Prostate Research
article

Does reducing the number of intradetrusor botulinum toxin type A injection sites affect efficacy and safety in patients with spinal cord injury?

Huang Maping, 刘秋玲, 谢克基, Heyi Zheng, Ping Tang, Yang Xiaoyi, Tianhai Huang, Conghui Hang, Mengxia Guo, Hongge Pang, Hui Chen
article en

Abstract

Objective To investigate the clinical effect and safety of different numbers of botulinum toxin type A (BTX-A) bladder injections in the treatment of neurogenic detrusor overactivity (NDO).Design A single-blind randomized control trial.Setting A single spinal cord injury (SCI) rehabilitation center in China.Participants A total of 44 patients with spinal cord injury and neurogenic detrusor overactivity who underwent intradetrusor injection of 200 U BTX-A were enrolled. The cohort included 34 men and 10 women.Interventions They were randomly divided into two groups of 30 vs. 20 sites of injection with 200 U BTX-A.Outcome Measures Urodynamic parameters such as maximum detrusor pressure at first DO (PdetmaxDO), volume at the first involuntary detrusor contraction, were measured at baseline and week 12 after injection. Mean urine volume per catheterization(V-CIC), scores of the Incontinence Specific Quality of Life Instrument (I-QoL) were also recorded before and after treatment.Results At the endpoint, both the urodynamic parameters and volume of catheterization improved significantly, without a significant difference between the two groups. Mean decreases in the maximum detrusor pressure were −31.95 and −25.77 cmH2O in the 20- and 30-injection groups. The increases in volume at the first involuntary detrusor contraction from baseline were +130.86 and +122.73 ml, respectively. There was no significant difference in the change in incontinence severity or I-QoL improvement between the two groups. The urinary incontinence episodes per week decreased from 48.41 ± 6.71–17.50 ± 16.17 and from 53.27 ± 11.33–22.91 ± 18.94 in the 20- and 30-injection groups, respectively (all P < 0.001). There were eight and seven patients with complete dryness after treatment.Conclusions When the total dose of 200 U was maintained, reducing the number of injection sites from 30 to 20 had a similar therapeutic effect in NDO without compromising safety. Clinically, this approach may be advantageous in terms of reducing the operating time and improving patient comfort.

Journal of Spinal Cord Medicine
Jiangsu Normal University (CN), Guangdong Work Injury Rehabilitation Hospital (CN), Guangzhou First People's Hospital (CN), Xuzhou Central Hospital (CN), Heyou Hospital (CN), South China University of Technology (CN)
Guangdong Medical Research Foundation, Basic and Applied Basic Research Foundation of Guangdong Province
Good health and well-being
Urinary Bladder and Prostate Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon